R01CA107420/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2007	2
2008	2
2009	1
2025	0

Page 1

Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.

Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. Kelber JA, et al. J Biol Chem. 2008 Feb 22;283(8):4490-500. doi: 10.1074/jbc.M704960200. Epub 2007 Dec 18. J Biol Chem. 2008. PMID: 18089557 Free article.

GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.

Shani G, Fischer WH, Justice NJ, Kelber JA, Vale W, Gray PC. Shani G, et al. Mol Cell Biol. 2008 Jan;28(2):666-77. doi: 10.1128/MCB.01716-07. Epub 2007 Nov 8. Mol Cell Biol. 2008. PMID: 17991893 Free PMC article.

Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.

Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC. Kelber JA, et al. Oncogene. 2009 Jun 18;28(24):2324-36. doi: 10.1038/onc.2009.97. Epub 2009 May 4. Oncogene. 2009. PMID: 19421146 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year